Exelixis Clinical Site #4 — Boston, Massachusetts

Exelixis Clinical Site #4 is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Exelixis Clinical Site #4 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Neoplasm Malignant, Renal Cell Carcinoma, Hormone Receptor Positive Breast Carcinoma.

Sponsors: Exelixis.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Exelixis Clinical Site #4?

Exelixis Clinical Site #4 has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Exelixis Clinical Site #4 conducted?

Exelixis Clinical Site #4 has 1 clinical trials on record, with 1 currently active. Their work covers Neoplasm Malignant, Renal Cell Carcinoma, Hormone Receptor Positive Breast Carcinoma.

Is Exelixis Clinical Site #4 accredited by Crixeo Health?

Exelixis Clinical Site #4 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Exelixis Clinical Site #4?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.